Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protamine Recombinant Human Insulin 30R vs NovoMix 30R in Type 2 Diabetes
CTR20170929Phase 3Completed
- Sponsor
- YiChang HEC ChangJiang Pharmaceutical
- Start
- Aug 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of biphasic human insulin in type 2 diabetes mellitus (T2DM), sponsored by YiChang HEC ChangJiang Pharmaceutical. Started Aug 2017; status: completed.
02
Drugs
biphasic human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20170929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170929.